Publications by authors named "Merlin C Thomas"

100Publications

Forensic interrogation of diabetic endothelitis in cardiovascular diseases and clinical translation in heart failure.

World J Cardiol 2020 Aug;12(8):409-418

Werribee Mercy Sub School, School of Medicine Sydney, University of Notre Dame, Northcote 3070, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4330/wjc.v12.i8.409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439453PMC
August 2020

Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes.

Diabetologia 2020 Jul 5;63(7):1424-1434. Epub 2020 May 5.

Neuropharmacology Laboratory, Baker Heart and Diabetes Institute, P.O. Box 6492, Melbourne, VIC, 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-020-05145-0DOI Listing
July 2020

Dicarbonyl-mediated AGEing and diabetic kidney disease.

J Nephrol 2020 Mar 13. Epub 2020 Mar 13.

Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40620-020-00718-zDOI Listing
March 2020

Non-invasive Risk Stratification for Coronary Artery Disease: Is It Time for Subclassifications?

Curr Cardiol Rep 2019 07 25;21(8):87. Epub 2019 Jul 25.

Northern and Central Adelaide Local Network, University of Adelaide, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11886-019-1174-0DOI Listing
July 2019

The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure.

Diabetologia 2018 10 22;61(10):2098-2107. Epub 2018 Aug 22.

Department of Medicine, Division of Nephrology, Toronto General Hospital, University of Toronto, 585 University Avenue, 8N-845, Toronto, ON, M5G 2N2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-018-4669-0DOI Listing
October 2018

Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.

Diabetes Obes Metab 2018 12 7;20(12):2759-2767. Epub 2018 Aug 7.

Folkhälsan Institute of Genetics, Folkhälsan Research Centre, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13456DOI Listing
December 2018

: Type 2 Diabetes and Readmission for Heart Failure.

Authors:
Merlin C Thomas

Clin Med Insights Cardiol 2018 5;12:1179546818779588. Epub 2018 Jun 5.

Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179546818779588DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992798PMC
June 2018

Effects of Diabetes Medications Targeting the Incretin System on the Kidney.

Clin J Am Soc Nephrol 2018 02 10;13(2):321-323. Epub 2018 Jan 10.

Department of Diabetes, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.10380917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967437PMC
February 2018

Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2.

Arterioscler Thromb Vasc Biol 2017 11 21;37(11):2195-2203. Epub 2017 Sep 21.

From the Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, Australia (C.S.M., E.B., S.M.K., S.K.M., J.V.M., J.G.); School of Applied and Biomedical Sciences, Faculty of Science and Technology, Federation University Australia, Mount Helen, Victoria (Y.W.); Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia (C.T., M.E.C., M.C.T.); School of Surgery, Fremantle Hospital, University of Western Australia (P.E.N.); Department of Medicine, University of Melbourne, Austin Hospital, Victoria, Australia (L.M.B.); and Department of Vascular and Endovascular Surgery, Townsville Hospital, Queensland, Australia (J.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.117.310129DOI Listing
November 2017

The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes.

Authors:
Merlin C Thomas

Diabetes Metab 2017 Apr;43 Suppl 1:2S20-2S27

Department of Diabetes, Monash University, Level 5, 99 Commercial Rd, Melbourne, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1262-3636(17)30069-1DOI Listing
April 2017

Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Kidney Int 2016 12;90(6):1175-1183

Diabetic Complications Division, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland; Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2016.09.010DOI Listing
December 2016

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure.

Clin Med Insights Cardiol 2016 12;10:163-171. Epub 2016 Oct 12.

Professor of Cardiology, Director, Cardiology Unit, Discipline of Medicine, Cardiology Research Laboratory, The Basil Hetzel Institute, Woodville South, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMC.S38444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063839PMC
October 2016

Phase 4 Studies in Heart Failure - What is Done and What is Needed?

Curr Cardiol Rev 2016;12(3):216-30

Cardiologist & Senior Lecturer NT Medical School, Flinders University, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011189PMC
http://dx.doi.org/10.2174/1573403x12666160606121458DOI Listing
December 2016

Type 2 Diabetes and Heart Failure: Challenges and Solutions.

Authors:
Merlin C Thomas

Curr Cardiol Rev 2016;12(3):249-55

Biochemistry of Diabetes Complications, Baker IDI Heart and Diabetes Institute, P.O. Box: 6492, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011193PMC
http://dx.doi.org/10.2174/1573403x12666160606120254DOI Listing
December 2016

Epigenetic Mechanisms in Diabetic Kidney Disease.

Authors:
Merlin C Thomas

Curr Diab Rep 2016 Mar;16(3):31

Baker IDI Heart & Diabetes Institute, 75 Commercial Rd, Melbourne, 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-016-0723-9DOI Listing
March 2016

Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial Homeostasis.

Diabetes 2016 04 28;65(4):1085-98. Epub 2016 Jan 28.

Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia Glycation and Diabetes Group, Mater Research Institute-University of Queensland, Translational Research Institute, Woolloongabba, South Brisbane, Queensland, Australia School of Medicine, Mater Clinical School, The University of Queensland, St. Lucia, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db15-0864DOI Listing
April 2016

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.

Nat Rev Nephrol 2016 Feb 10;12(2):73-81. Epub 2015 Nov 10.

Baker IDI Heart &Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2015.173DOI Listing
February 2016

Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.

Diabetes Care 2015 Oct 7;38(10):1891-7. Epub 2015 Aug 7.

The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc15-0925DOI Listing
October 2015

AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy.

Hypertension 2015 May 16;65(5):1073-81. Epub 2015 Mar 16.

From the Diabetic Complications Division, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (C.K., B.S.M.C., M.M., V.T.-B., M.C.T., M.E.C., K.A.J.-D., T.J.A.); the Department of Medicine, Monash University, Monash, Australia (M.C.T., M.E.C., K.A.J.-D., T.J.A.); IMM-Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense. Denmark (U.M.S.); and CARIM-School of Cardiovascular Diseases, Maastricht University, Maastricht, Netherlands (T.U.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.05204DOI Listing
May 2015

Diabetic kidney disease.

Nat Rev Dis Primers 2015 07 30;1:15018. Epub 2015 Jul 30.

Baker IDI Heart &Diabetes Institute, 75 Commercial Road, Melbourne, Victoria 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2015.18DOI Listing
July 2015

ACE2 deficiency shifts energy metabolism towards glucose utilization.

Metabolism 2015 Mar 20;64(3):406-15. Epub 2014 Nov 20.

Baker IDI Heart and Diabetes Institute, 75 Commercial Road 3004 VIC, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2014.11.004DOI Listing
March 2015

Origin of the Y chromosome influences intrarenal vascular responsiveness to angiotensin I and angiotensin (1-7) in stroke-prone spontaneously hypertensive rats.

Hypertension 2014 Dec 8;64(6):1376-83. Epub 2014 Sep 8.

From the Director's Research Group (A.K.S., G.L.J.), Department of Vascular Pharmacology (A.K.S., K.L.A., J.P.F.C.-D.), Department of Neuropharmacology (G.A.H.), and Department of Diabetic Complications (M.C.T.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; and Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (D.G., M.W.M., A.F.D.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.114.
Publisher Site
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03756DOI Listing
December 2014

Renal effects of dapagliflozin in patients with type 2 diabetes.

Authors:
Merlin C Thomas

Ther Adv Endocrinol Metab 2014 Jun;5(3):53-61

Baker IDI Heart & Diabetes Institute, 75 Commercial Rd, Melbourne, 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2042018814544153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132377PMC
June 2014

Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.

Diabetes Care 2014 Sep 26;37(9):2593-600. Epub 2014 Jun 26.

Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Folkhälsan Institute of Genetics, Folkhälsan Research Center, and the Diabetes and Obesity Research Program, Research Program's Unit, University of Helsinki, Helsinki, Finland Diabetic Complications, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-0065DOI Listing
September 2014

Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.

Atherosclerosis 2014 Aug 4;235(2):444-8. Epub 2014 Jun 4.

Diabetes Complications-Diabetes and The Kidney Laboratory, Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia; Department of Medicine, Central Clinical School, Monash University, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.945DOI Listing
August 2014

Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.

Diabetes Care 2014 Aug 30;37(8):2334-42. Epub 2014 May 30.

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, FinlandBaker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-0225DOI Listing
August 2014

Dicarbonyl stress in the absence of hyperglycemia increases endothelial inflammation and atherogenesis similar to that observed in diabetes.

Diabetes 2014 Nov 8;63(11):3915-25. Epub 2014 May 8.

Baker IDI Heart and Diabetes Institute, Melbourne, Australia Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db13-0932DOI Listing
November 2014

Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.

Authors:
Merlin C Thomas

Adv Chronic Kidney Dis 2014 May;21(3):311-7

Baker IDI Heart & Diabetes Institute and Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ackd.2014.03.004DOI Listing
May 2014

Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.

Am J Physiol Renal Physiol 2014 Apr 29;306(7):F773-80. Epub 2014 Jan 29.

Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Central, Melbourne 8008, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.00264.2013DOI Listing
April 2014

Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.

Kidney Int 2014 Feb 2;85(2):352-61. Epub 2013 Oct 2.

JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2013.372DOI Listing
February 2014

Diabetes: Assessing renal risk in patients with type 2 diabetes.

Nat Rev Nephrol 2013 Oct 17;9(10):559-60. Epub 2013 Sep 17.

Baker IDI Heart & Diabetes Institute, PO Box 6492, Melbourne, Vic 8008, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2013.181DOI Listing
October 2013

Coeliac disease, gluten-free diet and the development and progression of albuminuria in children with type 1 diabetes.

Pediatr Diabetes 2013 Sep 14;14(6):455-8. Epub 2013 Jun 14.

Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pedi.12028DOI Listing
September 2013

Emerging drugs for managing kidney disease in patients with diabetes.

Authors:
Merlin C Thomas

Expert Opin Emerg Drugs 2013 Mar 21;18(1):55-70. Epub 2013 Jan 21.

Baker IDI Heart and Diabetes Institute, St Kilda Rd Central, PO Box 6492, Melbourne, VIC 8008, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.2013.762356DOI Listing
March 2013

Angiotensin converting enzyme 2 and atherosclerosis.

Atherosclerosis 2013 Jan 20;226(1):3-8. Epub 2012 Aug 20.

The Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, Queensland 4811, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2012.08.018DOI Listing
January 2013

High nephron endowment protects against salt-induced hypertension.

Am J Physiol Renal Physiol 2012 Jul 9;303(2):F253-8. Epub 2012 May 9.

Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia.

View Article

Download full-text PDF

Source
http://ajprenal.physiology.org/content/ajprenal/303/2/F253.f
Web Search
http://ajprenal.physiology.org/content/ajprenal/early/2012/0
Web Search
http://ajprenal.physiology.org/cgi/doi/10.1152/ajprenal.0002
Publisher Site
http://dx.doi.org/10.1152/ajprenal.00028.2012DOI Listing
July 2012

Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.

Circ Res 2012 Apr 8;110(8):1067-76. Epub 2012 Mar 8.

Epigenetics in Human Health and Disease Laboratory, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.112.266171DOI Listing
April 2012

Towards understanding the inherited susceptibility for nephropathy in diabetes.

Curr Opin Nephrol Hypertens 2012 Mar;21(2):195-202

Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNH.0b013e328350313eDOI Listing
March 2012

Nutrient sensing, autophagy, and diabetic nephropathy.

Diabetes 2012 Jan;61(1):23-9

Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db11-0555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237646PMC
January 2012

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications.

J Hypertens 2012 Feb;30(2):375-83

Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, and Folkhälsan Research Center, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0b013e32834f04b6DOI Listing
February 2012

Bardoxolone: augmenting the Yin in chronic kidney disease.

Authors:
Merlin C Thomas

Diab Vasc Dis Res 2011 Oct;8(4):303-4

Baker IDI Heart and Diabetes Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1479164111421034
Publisher Site
http://dx.doi.org/10.1177/1479164111421034DOI Listing
October 2011

Diabetes: bardoxolone improves kidney function in type 2 diabetes.

Nat Rev Nephrol 2011 Aug 23;7(10):552-3. Epub 2011 Aug 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2011.114DOI Listing
August 2011

Post-translational modification of plant-made foreign proteins; glycosylation and beyond.

Biotechnol Adv 2012 Mar-Apr;30(2):410-8. Epub 2011 Aug 3.

School of Biological Sciences and the Department of Microbiology, Monash University, Clayton Vic, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biotechadv.2011.07.015DOI Listing
June 2012

New approaches to the treatment of nephropathy in diabetes.

Expert Opin Investig Drugs 2011 Aug 12;20(8):1057-71. Epub 2011 Jul 12.

University of Helsinki, Folkha¨lsan Research Center, Folkha¨lsan Institute of Genetics, Biomedicum, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.591785DOI Listing
August 2011

Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop.

Atherosclerosis 2011 Sep 27;218(1):61-8. Epub 2011 May 27.

Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2011.05.019DOI Listing
September 2011

Advanced glycation end products.

Authors:
Merlin C Thomas

Contrib Nephrol 2011 9;170:66-74. Epub 2011 Jun 9.

Baker IDI Heart and Diabetes Institute, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/324945
Publisher Site
http://dx.doi.org/10.1159/000324945DOI Listing
October 2011

Pathogenesis and progression of proteinuria.

Authors:
Merlin C Thomas

Contrib Nephrol 2011 9;170:48-56. Epub 2011 Jun 9.

Baker IDI Heart and Diabetes Institute, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/324943
Publisher Site
http://dx.doi.org/10.1159/000324943DOI Listing
October 2011

Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy.

Diabetes 2011 Jun 26;60(6):1779-88. Epub 2011 Apr 26.

JDRF Danielle Alberti Memorial Centre for Diabetes Complications,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria,Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db10-1110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114395PMC
June 2011

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.

Kidney Int 2011 Aug 30;80(3):282-7. Epub 2011 Mar 30.

Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2011.79DOI Listing
August 2011

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

J Am Soc Nephrol 2011 Mar 18;22(3):537-44. Epub 2011 Feb 18.

Folkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, University of Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2010020194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060447PMC
March 2011

Dietary salt intake and mortality in patients with type 2 diabetes.

Diabetes Care 2011 Mar 2;34(3):703-9. Epub 2011 Feb 2.

Endocrine Centre, Austin Health and the University of Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc10-1723DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041211PMC
March 2011

Into the light? Diabetic nephropathy and vitamin D.

Lancet 2010 Nov;376(9752):1521-2

Baker IDI Heart and Diabetes Institute, Melbourne, VIC 8008,Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)61304-9DOI Listing
November 2010

Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function.

Diabetes 2010 Dec 17;59(12):3208-15. Epub 2010 Sep 17.

Oxidative Stress Laboratory, Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db10-0552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992784PMC
December 2010

The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.

Am J Physiol Renal Physiol 2010 Sep 16;299(3):F528-35. Epub 2010 Jun 16.

Baker IDI Heart and Diabetes Institute, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.00127.2010DOI Listing
September 2010

The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology.

Expert Rev Mol Med 2010 May 27;12:e17. Epub 2010 May 27.

Division of Diabetic Complications, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1462399410001481DOI Listing
May 2010

High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment.

Am J Physiol Renal Physiol 2010 Jun 24;298(6):F1384-92. Epub 2010 Mar 24.

Department of Physiology, Monash University, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://ajprenal.physiology.org/content/ajprenal/298/6/F1384.
Web Search
http://ajprenal.physiology.org/cgi/doi/10.1152/ajprenal.0004
Publisher Site
http://dx.doi.org/10.1152/ajprenal.00049.2010DOI Listing
June 2010

Cardiovascular disease: what's all the AGE/RAGE about?

Cardiovasc Hematol Disord Drug Targets 2010 Mar;10(1):7-15

Baker IDI Heart and Diabetes Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/187152910790780050DOI Listing
March 2010

Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.

Am J Physiol Renal Physiol 2010 Mar 16;298(3):F763-70. Epub 2009 Dec 16.

Juvenile Diabetes Research Foundation Einstein Centre for Diabetic Complications, Baker International Diabetes Institute Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.00591.2009DOI Listing
March 2010

Low testosterone and anaemia in men with type 2 diabetes.

Clin Endocrinol (Oxf) 2009 Apr 13;70(4):547-53. Epub 2008 Aug 13.

Department of Endocrinology and Medicine, University of Melbourne, Austin Health, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2265.2008.03357.xDOI Listing
April 2009

Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus.

J Med Invest 2008 Feb;55(1-2):29-36

University of Melbourne, Department of Medicine, St Vincent's Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2152/jmi.55.29DOI Listing
February 2008

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

J Clin Endocrinol Metab 2008 May 4;93(5):1834-40. Epub 2008 Mar 4.

Department of Endocrinology and Medicine, University of Melbourne, Austin Health, Studley Road, Heidelberg, Victoria 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2007-2177DOI Listing
May 2008

PPAR Agonists and Cardiovascular Disease in Diabetes.

PPAR Res 2008 ;2008:245410

JDRF Center for Diabetes Complications, Baker Heart Research Institute, Melbourne, VIC 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2008/245410DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233765PMC
July 2011

ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes.

Diabetes 2008 Apr 30;57(4):1018-25. Epub 2008 Jan 30.

Danielle Alberti Memorial Centre for Diabetes Complications, Baker Medical Research Institute, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db07-1212DOI Listing
April 2008

The assessment and management of albuminuria in primary care.

Authors:
Merlin C Thomas

Diabetes Res Clin Pract 2008 Apr 21;80(1):83-8. Epub 2008 Feb 21.

Danielle Alberti Memorial Centre for Diabetic Complications, Baker Medical Research Institute, P.O. Box 6492, Melbourne, Victoria 8008, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2007.10.024DOI Listing
April 2008

Screening for chronic kidney disease in patients with diabetes: are we missing the point?

Nat Clin Pract Nephrol 2008 Jan 27;4(1):2-3. Epub 2007 Nov 27.

Diabetes and Metabolic Division, Baker Heart Research Institute, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpneph0679DOI Listing
January 2008

The management of diabetes in indigenous Australians from primary care.

BMC Public Health 2007 Oct 25;7:303. Epub 2007 Oct 25.

Department of Nephrology, Royal Perth Hospital, Box X 2213, Perth, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2458-7-303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174478PMC
October 2007

Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes.

Clin Sci (Lond) 2008 Feb;114(4):313-20

Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria 3081, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CS20070261DOI Listing
February 2008

HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.

Diabetes Care 2007 Oct 9;30(10):2706-7. Epub 2007 Jul 9.

Folkhälsan Research Center, Biomedicum Helsinki, P.O. Box 63, FIN-00014 University of Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc07-0030DOI Listing
October 2007

The use of oral antidiabetic agents in primary care.

Aust Fam Physician 2007 Jun;36(6):477-80

Servier Laboratories (Australia) Pty Ltd, Victoria, Australia.

View Article

Download full-text PDF

Source
June 2007

The CARI guidelines. Prevention of progression of kidney disease: autosomal-dominant polycystic kidney disease.

Nephrology (Carlton) 2007 Feb;12 Suppl 1:S52-6

Baker Heart Research Institute, St. Kilda Road Central, PO Box 6492, Melbourne, VIC 8008, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1797.2006.00720.xDOI Listing
February 2007